Czechia Infection Control Market Size, Share, Opportunities, COVID-19 Impact, And Trends By Product (Disinfectants, Sterilization (Low-Temperature Sterilization, Heat Sterilization, Contract Sterilization)), By End User Industry (Healthcare, Food And Beverage, Chemical) - Forecasts From 2022 To 2027

  • Published : Aug 2022
  • Report Code : KSI061613408
  • Pages : 90
excel pdf power-point

Czechia’s infection control market is evaluated at US$62.3 million for the year 2020 and is projected to grow at a CAGR of 5.43% to reach a market size of US$90.23 million by the year 2027. The market in the Czech Republic is projected to grow in the forecast period owing to the advanced healthcare facilities and the presence of renowned doctors in the world. Also, the country is also considered to be one of the favourite destinations for medical tourism in Europe, hence thus propelling the market demand in the forecast period and in the upcoming years. With a high demand for beauty treatments, Czechia is providing such treatments at affordable costs. Hence, the country has emerged as the most preferred destination and is continuing to attract medical tourists from abroad, further providing an opportunity for the market to thrive in the forecast period. Robotics research in the country is propagating the market demand with the growing research activities resulting in the development of robotic devices and their application in various fields. This is further providing an impetus for the market to grow at a significant pace in the forecast period. The use of robotics in surgery is also a trend in the Czech Republic.

The presence of fertility clinics in Czechia is driving the market growth in the forecast period.

The country offers excellent services in the case of infertility treatments. There are, at present, around 30 clinics with a high standard of treatment. Also, the clinics are well-regulated. Prague and Brno are the most popular cities for in-vitro fertilization (IVF), but there are other centres in different parts of the country offering fertility treatments that are economical. The IVF and egg donation success rates are also high, specifically, the egg donation rate. Additionally, the treatments are quite reasonable, leading to huge savings without compromising on quality and safety. Hence, IVF treatments are considered cost-effective in comparison to the United Kingdom. Talking Speaking in terms of safety, the IVF clinics in Czechia is well-regulated and well-monitored. All IVF clinics are required to carry a valid license in order to operate in this field. The license is granted by the State Institute for Drug Control and is responsible for the inspection of these fertility clinics every two years.

COVID-19 SCENARIO

The increasing incidence of nosocomial infections and the rising number of procedures that necessitate control measures to prevent spreading are the main factors driving the France infection control market. Approximately one in every 20 patients in for treatment will develop a nosocomial infection, according to the Centers for Disease Control and Prevention (CDC). Each year, hospital-acquired infections cause more than 99,000 fatalities. The absence of public awareness of infection control measures and onerous regulatory requirements are expected to restrain market expansion. However, it is anticipated that the market expansion would be fueled by government and non-government organizations' actions regarding infection control and the expanding control techniques used by healthcare practitioners in hospitals.

KEY DEVELOPMENT

  • July 2020- To assist safeguard the citizens of the Czech Republic, the Zentiva team in Prague created and produced a potent hand sanitizer. They recently passed the 1.5 million pack production milestone. Within 4 weeks following the initial implementation of COVID preventive measures, the hand sanitizer was created, produced, and distributed to Czech citizens. Since then, Zentiva has given more than 250,000 hand sanitizers to hospitals, medical professionals, important employees, and vulnerable residents.

Czechia Infection Control Market Scope:

 

Report Metric Details
 Market Size Value in 2020  US$62.3 million
 Market Size Value in 2027  US$90.23 million
 Growth Rate  CAGR of 5.43% from 2020 to 2027
 Base Year  2020
 Forecast Period  2022–2027
 Forecast Unit (Value)  USD Million
 Segments Covered  Product And End User Industry
 Companies Covered  3M, B. Braun Melsungen AG, Becton, Dickinson and Company, Schülke & Mayr GmbH, Franke Medical OY
 Customization Scope  Free report customization with purchase

 

Market Segmentation:

  • By Product
    • Disinfectant
    • Sterilization
      • Low temperature Sterilization
      • Heat Sterilization
      • Contract Sterilization
  • By End User Industry
    • Healthcare
    • Food and Beverage
    • Chemical
1. Introduction
1.1.  Market Overview
1.2. COVID-19 Scenario
1.3. Market Definition
1.4. Market Segmentation

2.  Research Methodology
2.1.  Research Data
2.2.  Assumptions

3.  Executive Summary
3.1.  Research Highlights

4. Market Dynamics
4.1. Market Drivers
4.2. Market Restraints
4.3. Porters Five Forces Analysis
4.3.1. Bargaining Power of Suppliers
4.3.2. Bargaining Power of Buyers
4.3.3. Threat of New Entrants
4.3.4.  Threat of Substitutes
4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis

5. Czechia Infection Control Market By Product
5.1.  Introduction
5.2. Disinfectant
5.3. Sterilization 
5.3.1.  Low-Temperature Sterilization
5.3.2.  Heat Sterilization
5.3.3. Contact Sterilization

6. Czechia Infection Control Market By End-User Industry
6.1. Introduction
6.2. Healthcare
6.3. Food and Beverage
6.4. Chemical

7. Competitive Environment and Analysis
7.1. Major Players and Strategy Analysis
7.2.  Emerging Players and Market Lucrativeness
7.3.  Mergers, Acquisitions, Agreements, and Collaborations
7.4.  Vendor Competitiveness Matrix

8. Companies Profiles
8.1. 3M
8.2. B. Braun Melsungen AG
8.3. Becton, Dickinson and Company
8.4. Schülke & Mayr GmbH
8.5. Franke Medical OY

3M

B. Braun Melsungen AG

Becton, Dickinson and Company

Schülke & Mayr GmbH

Franke Medical OY